A Monoclonal Antibody Specific for Human Thymidine Kinase 1
Authors:
- H LiHLH Li
- 1 February 2001
- journal article
- research article
- Published by SAGE Publications in Hybridoma
- Vol. 20 (1) , 25-34
Abstract
Previous research has shown that thymidine kinase 1 (TK1), a nucleotide salvage pathway enzyme, is an accurate prognostic and diagnostic tumor marker. However, the current radioisotope assay for TK1 is cumbersome and has hampered the clinical application of this diagnostic technique in cancer management. To overcome the problems of the current radioisotope assay, we have produced monoclonal antibodies (MAbs) using purified TK1 from Raji cell extract. Production and confirmation of their specificity was confirmed using Western blot, immunohistochemical staining, TK1 activity inhibition assays, and enzyme-linked immunoadsorbent assay (ELISA) techniques. Thus, in the future, these antibodies may aid in the early detection of cancer and more accurate prognosis, as well as allowing for an increased ability to study the function of TK1 in basic cellular processes.Keywords
This publication has 42 references indexed in Scilit:
- Different affinity of the two forms of human cytosolic thymidine kinase towards pyrimidine analogsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Clinical significance of serum thymidine kinase in adult T-cell leukaemia and acute myeloid leukaemiaBritish Journal of Haematology, 1995
- Serological tumor markers for small cell lung cancer and their therapeutic implicationsAPMIS, 1994
- Why do Most Primary Bladder Neoplasms First Appear Around the Ureteric Orifices?British Journal of Urology, 1993
- Can Thymidine Kinase Levels in Breast Tumors Predict Disease Recurrence?JNCI: Journal of the National Cancer Institute, 1992
- Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissuesBiochemical and Biophysical Research Communications, 1992
- Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applicationsAnnals of Hematology, 1992
- Increased activities of thymidine kinase isozymes in human colon polyp and carcinomaCarcinogenesis, 1985
- Biochemical markers in non‐Hodgkin's lymphoma stages III and IV and prognosis: A multivariate analysisScandinavian Journal of Haematology, 1984
- Studies on the biosynthesis of deoxyribonucleic acid by extracts of mammalian cells IV. The phosphorylation of thymidineBiochimica et Biophysica Acta, 1960